Literature DB >> 34649784

Effects of Dietary App-Supported Tele-Counseling on Sodium Intake, Diet Quality, and Blood Pressure in Patients With Diabetes and Kidney Disease.

Sarah J Schrauben1, Apurva Inamdar2, Christina Yule3, Sara Kwiecien3, Caitlin Krekel4, Charlotte Collins5, Cheryl Anderson6, Lisa Bailey-Davis7, Alex R Chang8.   

Abstract

OBJECTIVES: The aim of this study is to examine the effect of a telehealth intervention that used a dietary app, educational website, and weekly dietitian tele-counseling on sodium intake, diet quality, blood pressure, and albuminuria among individuals with diabetes and early-stage chronic kidney disease. DESIGN AND METHODS: We examined the effects of a dietary app-supported tele-counseling intervention in a single center, single arm study of 44 participants with type 2 diabetes and stage 1-3a chronic kidney disease. Participants recorded and shared dietary data via MyFitnessPal with registered dietitians, who used motivational interviewing to provide telephone counseling weekly for 8 weeks. After the 8-week intensive intervention, participants were followed at 6 and 12 months. Outcomes included 24-hour urine sodium (2 collections per timepoint), Healthy Eating Index 2015 score (three 24-hour dietary recalls per timepoint), 24-hour systolic blood pressure (SBP) and diastolic blood pressure (DBP), and 24-hour urine albumin excretion.
RESULTS: Out of 44 consented participants (mean age 60.3 ± 11.9 years, 43% female, 89% white, median estimated glomerular filtration rate was 78.5 mL/min/1.73 m2, median urine albumin excretion 52.9 mg/day, 84% hypertension), 32 (73%) completed 8-week follow-up, 27 (61%) completed 6-month follow-up, and 25 (57%) completed 12-month follow-up. Among participants who completed 12-month follow-up, reported sodium intake decreased by 638 mg/day from baseline of 2,919 mg/day (P < .001). The 24-hour mean urine sodium and albumin excretion did not decline over the study period. Healthy Eating Index 2015 score improved by 7.76 points at 12 months from a mean baseline of 54.6 (P < .001). Both 24-hour SBP and DBP declined at 12 months from baseline (SBP -5.7 mm Hg, 95% confidence interval -10.5 to -1.0, P = .02; DBP -4.1 mm Hg, 95% confidence interval -7.2 to -1.1, P = .01).
CONCLUSIONS: Overall, this study demonstrates that a short, intensive, remotely delivered dietary intervention for adults with type 2 diabetes and early chronic kidney disease at high risk for disease progression and cardiovascular complications led to improvement in blood pressure and self-reported sodium intake and diet quality, but no improvement in albuminuria. Future research studies are needed to examine whether remotely delivered dietary interventions can ultimately improve kidney health over time.
Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34649784      PMCID: PMC8727497          DOI: 10.1053/j.jrn.2021.08.006

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  43 in total

Review 1.  The transtheoretical model of health behavior change.

Authors:  J O Prochaska; W F Velicer
Journal:  Am J Health Promot       Date:  1997 Sep-Oct

2.  Medical Nutrition Therapy for Patients with Non-Dialysis-Dependent Chronic Kidney Disease: Barriers and Solutions.

Authors:  Holly Kramer; Elizabeth Yakes Jimenez; Deborah Brommage; Joseph Vassalotti; Elizabeth Montgomery; Alison Steiber; Marsha Schofield
Journal:  J Acad Nutr Diet       Date:  2018-07-31       Impact factor: 4.910

3.  The effects of protein intake on albuminuria in different estimated glomerular filtration rate: A population-based study.

Authors:  Yan Liu; Rong-Shao Tan; Dao-Yuan Zhou; Xiao Xiao; Jian-Min Ran; Dan-Ping Qin; Xiao-Shi Zhong; Jian-Guang Hu; Yun Liu; Yuan-Yuan Zheng
Journal:  Eur J Intern Med       Date:  2017-11-07       Impact factor: 4.487

4.  Assessing the value of diabetes education.

Authors:  Ian Duncan; Christian Birkmeyer; Sheryl Coughlin; Qijuan Emily Li; Dawn Sherr; Sue Boren
Journal:  Diabetes Educ       Date:  2009 Sep-Oct       Impact factor: 2.140

5.  Communicating personalized risk of diabetes and offering weight reduction program choice: Recruitment, participation, and outcomes.

Authors:  Lisa Bailey-Davis; G Craig Wood; Adam Cook; Krystal Cunningham; Scott Jamieson; Jacob Mowery; Allison Naylor; David D Rolston; Christopher Seiler; Christopher D Still
Journal:  Patient Educ Couns       Date:  2020-10-12

6.  Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.

Authors:  Nimrit Goraya; Jan Simoni; Chan-Hee Jo; Donald E Wesson
Journal:  Kidney Int       Date:  2014-04-02       Impact factor: 10.612

7.  Trends in Diabetes Management Among US Adults: 1999-2016.

Authors:  Michael Fang
Journal:  J Gen Intern Med       Date:  2020-01-02       Impact factor: 5.128

8.  Net endogenous acid production is associated with a faster decline in GFR in African Americans.

Authors:  Julia J Scialla; Lawrence J Appel; Brad C Astor; Edgar R Miller; Srinivasan Beddhu; Mark Woodward; Rulan S Parekh; Cheryl A M Anderson
Journal:  Kidney Int       Date:  2012-04-04       Impact factor: 10.612

Review 9.  How smartphones are changing the face of mobile and participatory healthcare: an overview, with example from eCAALYX.

Authors:  Maged N Kamel Boulos; Steve Wheeler; Carlos Tavares; Ray Jones
Journal:  Biomed Eng Online       Date:  2011-04-05       Impact factor: 2.819

10.  Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.

Authors:  Roy Taylor; Wilma S Leslie; Alison C Barnes; Naomi Brosnahan; George Thom; Louise McCombie; Naveed Sattar; Paul Welsh; Carl Peters; Sviatlana Zhyzhneuskaya; Kieren G Hollingsworth; Ahmad Al-Mrabeh; Angela M Rodrigues; Lucia Rehackova; Ashley J Adamson; Falko F Sniehotta; John C Mathers; Hazel M Ross; Yvonne McIlvenna; Sharon Kean; Ian Ford; Alex McConnachie; Michael E J Lean
Journal:  Diabetologia       Date:  2017-11-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.